Jump to:
loading...| Preferred Name |
Pumitepa |
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C73239 |
| CAS_Registry |
42061-52-9 |
| Chemical_Formula |
C12H19N8OP |
| code |
C73239 |
| Concept_In_Subset | |
| Contributing_Source |
FDA |
| DEFINITION |
A thiotepa derivative with potential antineoplastic alkylating activity. Although the exact mechanism of action of pumitepa has yet to be fully elucidated, this agent appears to work through alkylation, thereby causing DNA damage and cell cycle arrest. |
| FDA_UNII_Code |
7AYY495RE0 |
| FULL_SYN |
Fopurin |
| label |
Pumitepa |
| Legacy_Concept_Name |
Pumitepa |
| Preferred_Name |
Pumitepa |
| prefixIRI |
C73239 |
| prefLabel |
Pumitepa |
| Semantic_Type |
Pharmacologic Substance |
| UMLS_CUI |
C0060632 |
| subClassOf |
Create New Mapping
| Delete | Mapping To | Ontology | Source |
|---|---|---|---|
| http://purl.bioontology.org/ontology/MESH/C015893 | Medical Subject Headings | LOOM |